|
RBM41 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.200800E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.823000E-03 |
| Normal-vs-Stage2 |
8.764000E-02 |
| Normal-vs-Stage3 |
6.362000E-02 |
| Normal-vs-Stage4 |
2.845900E-02 |
| Stage1-vs-Stage2 |
7.872800E-01 |
| Stage1-vs-Stage3 |
7.903600E-01 |
| Stage1-vs-Stage4 |
9.471000E-01 |
| Stage2-vs-Stage3 |
6.779400E-01 |
| Stage2-vs-Stage4 |
8.363200E-01 |
| Stage3-vs-Stage4 |
7.877200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.444500E-03 |
| Normal-vs-AfricanAmerican |
4.728600E-01 |
| Normal-vs-Asian |
3.274400E-02 |
| Caucasian-vs-AfricanAmerican |
2.895600E-01 |
| Caucasian-vs-Asian |
4.648600E-01 |
| AfricanAmerican-vs-Asian |
3.098200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.676900E-03 |
| Normal-vs-Female |
7.739300E-03 |
| Male-vs-Female |
7.753600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.435800E-01 |
| Normal-vs-Age(41-60Yrs) |
9.573100E-04 |
| Normal-vs-Age(61-80Yrs) |
2.442400E-02 |
| Normal-vs-Age(81-100Yrs) |
7.143000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.074500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.464200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.562200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.456400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.931970E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.458400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.679500E-03 |
| Normal-vs-Grade 2 |
7.644400E-04 |
| Normal-vs-Grade 3 |
4.963700E-02 |
| Normal-vs-Grade 4 |
7.422400E-01 |
| Grade 1-vs-Grade 2 |
4.395200E-01 |
| Grade 1-vs-Grade 3 |
5.629800E-02 |
| Grade 1-vs-Grade 4 |
1.827600E-02 |
| Grade 2-vs-Grade 3 |
7.381700E-02 |
| Grade 2-vs-Grade 4 |
7.135900E-03 |
| Grade 3-vs-Grade 4 |
1.262760E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.28080000000053E-05 |
| Normal-vs-ccB subtype |
2.745000E-01 |
| ccA subtype-vs-ccB subtype |
1.676200E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.862200E-03 |
| Normal-vs-N1 |
7.252800E-01 |
| N0-vs-N1 |
4.124600E-01 |
|
|
